Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:00:13.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Removed the government funding and operating status notice from the page; core study details such as inclusion criteria, endpoints, and treatment information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:16:28.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The study status is updated to Terminated due to slow patient accrual. Results have been added with Results First Posted on 2020-09-16.
    Difference
    0.4%
    Check dated 2025-11-03T12:53:07.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    2%
    Check dated 2025-10-05T17:37:19.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0: version metadata updated; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:54:23.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:43:36.000Z thumbnail image

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.